Product review of DrugPatentWatch (key advantages; introduction; contact details)
Jinfo Article
19th January 2018
By Scott Vine
Abstract
We carry out an in-depth product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs and patents and was founded by Yali Friedman, named one of the 100 most influential people in biotechnology. Part one of the review introduces the product and company behind it, along with its key advantages, competitors and how the product is likely to evolve.
Note: Full review (PDF) at /go/sub/report/2934
Content Access
Access to Jinfo Content and Community is available through a Jinfo Subscription.
Does your organisation have a Jinfo Subscription?
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Product review of DrugPatentWatch (key advantages; introduction; contact details)
- Link to this page
- View printable version
- Product review of DrugPatentWatch (value - help & training; competitors; development; pricing)
Wednesday, 24th January 2018 - Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
Tuesday, 23rd January 2018 - Product review of DrugPatentWatch (sources - content & coverage)
Monday, 22nd January 2018
- Product review of DrugPatentWatch
Friday, 19th January 2018
Vendor adoption of AI
Community session
23rd May 2024
Mainstream GenAI, emerging vendors and your offshore resourcing strategy
Blog posting
9th May 2024
May 2024 Update
YouTube video
9th May 2024
- Jinfo Community session (TBC) (Community) 16th July 2024
- Jinfo Community session (TBC) (Community) 18th June 2024
- Vendor adoption of AI (Community) 23rd May 2024